A Coordination and Support Action to prepare UNCAN.eu platform

HealthHORIZON-CSAID: 101069496
EC Contribution
โ‚ฌ29,896
Consortium Size
31 orgs
Start Year
2022
โ–ถSummary

The 15-month coordination and support action โ€œ4.UNCAN.euโ€ will generate a strategic agenda to launch UNCAN.eu, a European initiative to UNderstand CANcer proposed by the Mission Board and the European Beating Cancer Plan. This research agenda will be built with the final aim of achieving a new breakthrough in cancer prevention and treatment that will contribute to saving European citizensโ€™ lives and help ensuring an optimal quality of life to disease survivors. To reach a new level of understanding, UNCAN.eu will take advantage of recent advances in research data generation and data sciences. Reliable, high-quality cancer research data generated by experimental model analysis and collected from longitudinal follow-up of cancer patients will be shared and integrated at an unprecedented scale within a Federated Cancer Research data hub, in the context of the General Data Protection Regulation. This information will be used by relevant players in Europe and beyond to address urgent and essential scientific and medical challenges in cancer prevention, early diagnosis, treatment and survivorship, in males and females of various ages. These challenges, identified in close interaction with European patients and citizens, will be tackled through competitive, ambitious and innovative, cross-border and trans-disciplinary research programmes built in a problem-solving manner. The definition of challenges will integrate inequalities in cancer research across regions and member states in order to boost the research potential of less-developed regions in Europe. Players will be committed to open science principles, including FAIR (findable, accessible, interoperable, and reusable) guiding principles for scientific data collection, management and stewardship. The new understanding gained from the collection and analysis of this wealth of data will apply secondarily to other diseases.

Consortium (31)

๐Ÿ‡ซ๐Ÿ‡ท INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEFR
coordinator
๐Ÿ‡ฎ๐Ÿ‡น ALLEANZA CONTRO IL CANCROIT
partner
๐Ÿ‡ธ๐Ÿ‡ฐ BIOMEDICINSKE CENTRUM SLOVENSKEJ AKADEMIE VIED, VEREJNA VYSKUMNA INSTITUCIASK
partner
๐Ÿ‡ซ๐Ÿ‡ท CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCERFR
partner
๐Ÿ‡ณ๐Ÿ‡ฑ CHILDHOOD CANCER INTERNATIONALNL
partner
๐Ÿ‡ช๐Ÿ‡ธ CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.ES
partner
๐Ÿ‡ฉ๐Ÿ‡ช DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERGDE
partner
๐Ÿ‡ง๐Ÿ‡ช EUROPEAN CANCER PATIENT COALITIONBE
partner
๐Ÿ‡ช๐Ÿ‡ธ FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)ES
partner
๐Ÿ‡ซ๐Ÿ‡ฎ HELSINGIN YLIOPISTOFI
partner
๐Ÿ‡ซ๐Ÿ‡ท INSERM TRANSFERT SAFR
partner
๐Ÿ‡ซ๐Ÿ‡ท INSTITUT NATIONAL DU CANCER GIPFR
partner
๐Ÿ‡ต๐Ÿ‡น INSTITUTO PORTUGUES DE ONCOLOGIA DO PORTO FRANCISCO GENTIL, EPEPT
partner
๐Ÿ‡ธ๐Ÿ‡ฎ KEMIJSKI INSTITUTSI
partner
๐Ÿ‡ฑ๐Ÿ‡บ LUXEMBOURG INSTITUTE OF HEALTHLU
partner
๐Ÿ‡จ๐Ÿ‡ฟ MASARYKUV ONKOLOGICKY USTAVCZ
partner
๐Ÿ‡ฆ๐Ÿ‡น MEDIZINISCHE UNIVERSITAET WIENAT
partner
๐Ÿ‡ฒ๐Ÿ‡น MINISTERU GHAS-SAHHA U L-ANZJANITA ATTIVAMT
partner
๐Ÿ‡ต๐Ÿ‡ฑ NARODOWY INSTYTUT ONKOLOGII IM. MARII SKLODOWSKIEJ-CURIE -PANSTWOWY INSTYTUT BADAWCZYPL
partner
๐Ÿ‡ง๐Ÿ‡ช ORGANISATION OF EUROPEAN CANCER INSTITUTESBE
partner
๐Ÿ‡ญ๐Ÿ‡บ Orszagos Onkologiai IntezetHU
partner
๐Ÿ‡ฉ๐Ÿ‡ฐ REGION NORDJYLLAND (NORTH DENMARK REGION)DK
partner
๐Ÿ‡ง๐Ÿ‡ช SCIENSANOBE
partner
๐Ÿ‡ง๐Ÿ‡ช SIOP EUROPEBE
partner
๐Ÿ‡ณ๐Ÿ‡ฑ STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUISNL
partner
๐Ÿ‡ณ๐Ÿ‡ฑ STICHTING INTEGRAAL KANKERCENTRUM NEDERLANDNL
partner
๐Ÿ‡ณ๐Ÿ‡ฑ STICHTING ONCODE INSTITUTENL
partner
๐Ÿ‡ช๐Ÿ‡ช TARTU ULIKOOLEE
partner
๐Ÿ‡ซ๐Ÿ‡ท UNIVERSITE PARIS-SACLAYFR
partner
๐Ÿ‡ฎ๐Ÿ‡ช UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLINIE
partner
๐Ÿ‡ฑ๐Ÿ‡น VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOSLT
partner